Welcome to ADVAC

ADVAC is a two-week training programme for decision-makers, including academia, industry, governmental and non-governmental agencies. The Course aims to facilitate critical decision-making in vaccinology by providing participants with a comprehensive overview of the various aspects of vaccinology (immunology, vaccine development, clinical trials, regulatory processes, vaccine-specific issues including new vaccines, vaccination strategies and policies, programme implementation, humanitarian emergencies, social, economic, political and ethical issues, financing, and communications…).

Read more

ADVAC - Advanced Course of Vaccinology


The 22nd ADVAC will take at Les Pensières, Annecy, France
from 9 to 20 May 2022.

The website is now closed for applications to the Course in 2022
and will reopen on 1 July 2022 for applications to the Course in 2023.

Feature lectures 2021

Special lecture:  THE 5th LAMBERT LECTURE
Interactions between the immune system and the microbiota – pdfYasmine Belkaid
Addressing vaccine hesitancy – videoNoni MacDonald
Impact of vaccination on disease epidemiology – videoRoy Anderson
Special lecture:  THE 13TH PLOTKIN LECTURE
Yellow fever – videoThomas Monath
Vaccines against epidemic and orphan diseases: How new technologies can change vaccine development –  videoBarney Graham
Available COVID vaccines with focus on effectiveness and safety, what we know and what we do not know – videoMelanie Saville
Highlights from ADVAC 2021 – videoRomina Libster

Scientific Committee

Course Director

Philippe Duclos, University of Geneva


Senior Scientific Advisors

Paul-Henri Lambert, University of Geneva

Stanley Plotkin, University of Pennsylvania, Vaxconsult


Members

Claire-Anne Siegrist
Executive Director ADVAC 
University of Geneva

Edwin Asturias
Children's Hospital Colorado

Michael Makanga
European & Developing Countries Clinical Trials Partnership

Ananda Bandyopadhyay
Bill & Melinda Gates Foundation

Mark Miller
University of Gothenburg
Tarik Derrough
European Centre for Disease Prevention and Control (ECDC)
Kathleen Neuzil (NFID representative)
Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Anna Durbin
Johns Hopkins Bloomberg School of Public Health

Hanna Nohynek
National Institute for Health and Welfare, Finland

Emily Erbelding
National Institutes of Health

Melanie Saville
Coalition for Epidemic Preparedness Innovations (CEPI)

Adam Finn (ESPID representative)
University of Bristol

Melinda Wharton
US Centers for Disease Control and Prevention

Martin Friede
World Health Organization

Annelies Wilder-Smith
Fondation Mérieux

Roger Glass
Fogarty International Centre

 

Criteria of participation as a Scientific Committee member

A member must comply with all three criteria below:

  1. Belongs to at least one of the following categories:
    • Founding member
    • Representative of an organizing institution (1 member per institution)
    • Representative of a co-sponsor organization (1 member per institution) nominated by his/her organization and endorsed by the Scientific Committee
    • Active coordination responsibilities during the ADVAC course.

  2. Scientific background and knowledge of vaccinology.

  3. Not directly employed by vaccine manufacturing companies.

The appointment of Scientific Committee members is personal and endorsed by the Scientific Committee prior to the appointment of the members on the Committee.

Representatives of co-sponsors are nominated by their organization and endorsed by the Scientific Committee prior to appointment of the members on the Committee.


Roles and responsibilities of a Scientific Committee member

  • Contributes to the elaboration of the program of the Course and the approval of the budget (Autumn meeting).
  • Contributes to the pre-selection of candidates through the scoring of at least one category of participants.
  • Contributes to the final selection of the candidates and of the Course preparation (January/early February meeting).
  • Contributes to the selection of the themes and the facilitation of the Alumni meetings (year-round).
  • Provides advice on key decisions concerning the Course (year-round) including funding or in-kind contributions, co-sponsors, and registrations fees.
  • Provides advice on the definition and adjustments of the ADVAC objectives.
The presence of SC members for at least one day of the ADVAC course is encouraged in order to have a real feel for the Course while engaging in networking activities with participants.

About us

ADVAC is an annual two-week training programme for decision-makers, including academia, industry, governmental and non-governmental agencies.

The Course aims to facilitate critical decision-making in vaccinology by providing participants with a comprehensive overview of the various aspects of vaccinology (immunology, vaccine development, clinical trials, regulatory processes, vaccine-specific issues including new vaccines, vaccination strategies and policies, programme implementation, humanitarian emergencies, social, economic, political and ethical issues, financing, and communications…).

 



merieux fondation logo uni ge logo
Organized by Fondation Mérieux & Université de Genève,
at "Les Pensières", Center for Global Health, Veyrier-du-Lac, France, close to Annecy and Geneva.

ADVAC is co-sponsored by:

  • Bill & Melinda Gates Foundation
  • Centers for Disease Control and Prevention (CDC)
  • Coalition for Epidemic Preparedness Innovations (CEPI) 
  • European Centre for Disease Prevention and Control (ECDC)
  • European & Developing Countries Clinical Trials Partnership (EDCTP)
  • European Society for Paediatric Infectious Diseases (ESPID)
  • Fondation Mérieux
  • Johns Hopkins Bloomberg School of Public Health
  • National Foundation for Infectious Diseases (NFID)
  • National Institutes of Health (NIH/NIAID-USA) and Fogarty International Center
  • University of Geneva
  • World Health Organization

Funding

ADVAC is funded by the participants’ registration fees, education grants, and in-kind contributions from the organizing and co-sponsoring agencies. Fellowships for selected ADVAC participants are supported by grant funding from the Bill & Melinda Gates Foundation, the European & Developing Countries Clinical Trials Partnership (EDCTP), the European Society for Paediatric Infectious Diseases (ESPID), and the National Foundation for Infectious Diseases (NFID).

Education grants are provided by:
Coalition for Epidemic Preparedness Innovations • GlaxoSmithKline • Janssen Vaccines & Prevention B.V. • Merck • Pfizer • Sanofi Pasteur • Serum Institute of India • Takeda

 

Meetings

  • WEBINAR

    Discussion topic:
    The impact of COVID on pneumococcal disease in children

    Presenter:
    Professor Ron Dagan
    Distinguished Professor of Pediatrics and Infectious Diseases, Soroka University Medical Center, Beer-Sheva, Israel


    Read More
  • WEBINAR

    Discussion topic:
    HPV vaccination: Prospect of moving to a one and only dose schedule

    Presenter:
    Margaret Stanley
    University of Cambridge, UK
    play webinar

    Read More
  • Second Workshop of the Global Collaboration
    on Advanced Vaccinoogy Training

    On 22-24 March 2022, ADVAC organized the 2nd Global Workshop on Advanced Vaccinology Training (ICAVT) which aims to assist courses in addressing challenges in priority areas, and facilitate interactions and exchange of information.
    Leaders of thirty-three advanced vaccinology courses were invited to meet with partners to further the aims of the International Collaboration on Advanced Vaccinology Training (ICAVT) initiated at the 1st Global Workshop on Advanced Vaccinology Training organized by ADVAC in 2018.

    Read More
  • WEBINAR

    Discussion topic:
    Safety of COVID-19 Vaccines

    Presenters:

    Rita Helfand, Chair, Global Advisory Committee on Vaccine Safety,...
    Tom Shimabukuro, Deputy Director, Immunization Safety Office,...
    play webinar

    Read More
  • WEBINAR

    Discussion topic:
    Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines?
    Presenters:
    Barney Graham, previously with the National Institute of Health, USA
    Philip Krause, Food & Drug Administration, USA
    play webinar

    Read More
  • WEBINAR (ENG)

    Discussion topic:
    COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity?
    Presenters:
    Dr Jakob Cramer, Coalition for Epidemic Preparedness Innovations (CEPI)
    Dr Jerome Kim, International Vaccine Institute, Seoul, Republic of Korea
    play webinar

    Read More

E-Portal

ADVAC has partnered with other training institutions to compile a listing of existing vaccinology courses available globally.

Click below to access the Global Vaccine Training e-Portal.

E-PORTAL

Login Form